BMC Medical Co. Ltd. A (301367) — Cash Flow Reinvestment Rate
BMC Medical Co. Ltd. A (301367) has a Cash Flow Reinvestment Rate of 6.50x as of December 2025, reinvesting CN¥846.58 Million (capex CN¥32.22 Million plus investments CN¥814.36 Million) from operating cash flow of CN¥130.16 Million. Check 301367 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BMC Medical Co. Ltd. A Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for BMC Medical Co. Ltd. A across 6 annual periods. Explore BMC Medical Co. Ltd. A debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for BMC Medical Co. Ltd. A (2020–2025)
Year-by-year capital reinvestment analysis for BMC Medical Co. Ltd. A. For live market cap and broader valuation context, see market cap of BMC Medical Co. Ltd. A.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 6.50x | CN¥846.58 Million | CN¥130.16 Million | CN¥32.22 Million | ▲ +76.3% |
| 2024 | 3.69x | CN¥568.33 Million | CN¥154.08 Million | CN¥15.93 Million | ▲ +71.0% |
| 2023 | 2.16x | CN¥326.03 Million | CN¥151.11 Million | CN¥24.12 Million | ▼ -57.4% |
| 2022 | 5.06x | CN¥1.90 Billion | CN¥375.21 Million | CN¥23.75 Million | ▲ +185.9% |
| 2021 | 1.77x | CN¥184.90 Million | CN¥104.40 Million | CN¥10.03 Million | ▲ +475.7% |
| 2020 | 0.31x | CN¥82.26 Million | CN¥267.41 Million | CN¥15.43 Million | — |